Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
WuXi Biologics Successfully Completes PFS Filling at its Robotic Aseptic Filling Facility
2020-04-28 08:00
WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany
2020-04-22 08:00
WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection
2020-04-14 08:00
WuXi Biologics Achieved Remarkable Results in 2019
2020-03-26 21:32
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
2020-03-11 08:00
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
2020-02-25 21:30
WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321
2020-02-24 08:00
WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
2020-02-18 18:42
WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
2020-02-18 18:18
WuXi Biologics Provides Back-to-work Operation Update Related to the Coronavirus Outbreak
2020-02-12 08:00
WuXi Biologics Provides Operation Update Related to the Coronavirus Outbreak
2020-01-29 10:44
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
2020-01-29 10:00
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
2020-01-16 10:39
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases
2020-01-09 17:10
WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392
2020-01-02 08:08
WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters
2019-12-23 16:26
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland
2019-11-23 01:55
WuXi Biologics Reports Outstanding Interim Results
2019-08-19 22:09
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing
2019-06-21 08:39
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract
2019-05-21 07:30
1
3
4
5
6
7
9